Deriving a Data-Based Interspecies Assessment Factor Using the NOAEL and the Benchmark Dose Approach

REFERENCES

• Adolph E. F. Quantitative relations in the physiological constitutions of mammals. Science 1949; 109: 579–585
   PubMed Web of Science ®Google Scholar
• Agutter P. S., Wheatley D. N. Metabolic scaling: Consensus or controversy?. Theor. Biol. Med. Model 2004; 1(1)13
   Google Scholar
• Baird S. J.S., Cohen J. T., Graham J. D., Shlyakhter A. I., Evans J. S. Noncancer risk assessment: A probabilistic alternative to current practice. Hum. Ecol. Risk Assess. 1996; 2(1)79–102
   Web of Science ®Google Scholar
• Bokkers B. G.H., Slob W. A comparison of ratio distributions based on the NOAEL and the benchmark approach for subchronic-to-chronic extrapolation. Toxicol. Sci. 2005; 85(2)1033–1040
   PubMed Web of Science ®Google Scholar
• Bokkers B. G.H., Slob W. Interspecies differences in toxicokinetics, (in prep.)
   Google Scholar
• Brand K. P., Rhomberg L., Evans J. S. Estimating noncancer uncertainty factors: Are ratios NOAELs informative?. Risk Anal. 1999; 19(2)295–308
   PubMed Web of Science ®Google Scholar
• Brix A. E., Nyska A., Haseman J. K., Sells D. M., Jokinen M. P., Walker N. J. Incidences of selected lesions in control female Harlan Sprague-Dawley rats from two-year studies performed by the National Toxicology Program. Toxicol. Pathol. 2005; 33(4)477–483
   Google Scholar
• Chappell W. R. Scaling toxicity data across species. Environ. Geochem. Health 1992; 14(3)71–80
   Google Scholar
• Crump K. S. A new method for determining allowable daily intakes. Fundam. Appl. Toxicol. 1984; 4(5)854–871
   PubMedGoogle Scholar
• Dekkers S., de Heer C., Rennen M. A. Critical effect sizes in toxicological risk assessment: A comprehensive and critical evaluation. Environ. Toxicol. Pharmacol. 2001; 10(1–2)33–52
   Google Scholar
• Dixon D., Heider K., Elwell M. R. Incidence of nonneoplastic lesions in historical control male and female Fischer-344 rats from 90-day toxicity studies. Toxicol. Pathol. 1995; 23(3)338–348
   PubMed Web of Science ®Google Scholar
• Dourson M. L., Knauf L. A., Swartout J. C. On reference dose (RfD) and its underlying toxicity data base. Toxicol. Ind. Health 1992; 8(3)171–189
   PubMed Web of Science ®Google Scholar
• Dourson M. L., Stara J. F. Regulatory history and experimental support of uncertainty (safety) factors. Regul. Toxicol. Pharmacol. 1983; 3(3)224–238
   PubMedGoogle Scholar
• Dybing E., Doe J., Groten J., Kleiner J., O'Brien J., Renwick A., Schlatter J., Steinberg P., Tritscher A., Walker R., Younes M. Hazard characterisation of chemicals in food and diet: Dose response, mechanism and extrapolation issues. Food Chem. Toxicol. 2002; 40: 237–282
   PubMed Web of Science ®Google Scholar
• Edler L., Poirier K., Dourson M., Kleiner J., Mileson B., Nordmann H., Renwick A., Slob W., Walton K., Wurtzen G. Mathematical modelling and quantitative methods. Food Chem. Toxicol. 2002; 40(2–3)283–326
   PubMed Web of Science ®Google Scholar
• Glazier D. S. Beyond the “3/4-power law': Variation in the intra-and interspecific scaling of metabolic rate in animals. Biol. Rev. Camb. Philos. Soc. 2005; 80(4)611–662
   PubMed Web of Science ®Google Scholar
• Goodman D. G., Ward J. M., Squire R. A., Chu K. C., Linhart M. S. Neoplastic and nonneoplastic lesions in aging F344 rats. Toxicol. Appl. Pharmacol. 1979; 48(2)237–248
   Google Scholar
• Goodman D. G., Ward J. M., Squire R. A., Paxton M. B., Reichardt W. D., Chu K. C., Linhart M. S. Neoplastic and nonneoplastic lesions in aging Osborne-Mendel rats. Toxicol. Appl. Pharmacol. 1980; 55(3)433–447
   Google Scholar
• Hard G. C., Khan K. N. A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment. Toxicol. Pathol. 2004; 32(2)171–180
   PubMed Web of Science ®Google Scholar
• Hayssen V., Lacy R. C. Basal metabolic rates in mammals: Taxonomic differences in the allometry of BMR and body mass. Comp. Biochem. Physiol. A 1985; 81(4)741–754
   Google Scholar
• Ings R. M.J. Interspecies scaling and comparison in drug development and toxicokinetics. Xenobiotica 1990; 20(11)1201–1231
   PubMed Web of Science ®Google Scholar
• Kleiber M. Body size and metabolism. Hilgardia 1932; 6(11)315–353
   Google Scholar
• Kleiber M. Body size and metabolic rate. Physiol. Rev. 1947; 27(4)511–541
   PubMed Web of Science ®Google Scholar
• Kramer H. J., van den Ham W. A., Slob W., Pieters M. N. Conversion factors estimating indicative chronic no-observed-adverse-effect levels from short-term toxicity data. Regul. Toxicol. Pharmacol. 1996; 23(3)249–255
   Google Scholar
• Leisenring W., Ryan L. Statistical properties of the NOAEL. Regul. Toxicol. Pharmacol. 1992; 15: 161–171, (2 Pt 1)
   PubMed Web of Science ®Google Scholar
• Lin J. H. Species similarities and differences in pharmacokinetics. Drug Metab. Dispos. 1995; 23(10)1008–1021
   PubMed Web of Science ®Google Scholar
• Lock E. A., Hard G. C. Chemically induced renal tubule tumors in the laboratory rat and mouse: Review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information. Crit. Rev. Toxicol. 2004; 34(3)211–299
   Web of Science ®Google Scholar
• Moerbeek M., Piersma A. H., Slob W. A comparison of three methods for calculating confidence intervals for the Benchmark Dose. Risk Anal. 2004; 24(1)31–40
   PubMed Web of Science ®Google Scholar
• OECD. Guideline 452, Chronic toxicity studies (adopted 12 May 1981). OECD guidelines for the testing of chemicals, Section 4: Health effects. Organisation for Economic Cooperation & Development, ParisFrance 1981
   Google Scholar
• OECD. Guideline 408, Repeated dose 90-day oral toxicity study in rodents (updated guideline, adopted 21st September 1998). OECD guidelines for the testing of chemicals, Section 4: Health effects. Organisation for Economic Cooperation & Development, Paris 1998
   Google Scholar
• Olson H., Betton G., Robinson D., Thomas K., Monro A., Kolaja G., Lilly P., Sanders J., Sipes G., Bracken W., Dorato M., Van Deun K., Smith P., Berger B., Heller A. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. 2000; 32(1)56–67
   PubMed Web of Science ®Google Scholar
• Pieters M. N., Kramer H. J., Slob W. Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: Statistical analysis of toxicity data. Regul. Toxicol. Pharmacol. 1998; 27(2)108–111
   PubMedGoogle Scholar
• Rao G. N. Diet and kidney diseases in rats. Toxicol Pathol. 2002; 30(6)651–656
   Google Scholar
• Rennen M. A.J., Hakkert B. C., Stevenson H., Bos P. M.J. Data-based derived values for the interspecies extrapolation, a quantitative analysis of historical toxicity data. Comments Toxicol. 2001; 7(5–6)423–436
   Google Scholar
• Rhomberg L. Separating pharmacokinetic and pharmacodynamic components in empirical adjustment factor distributions. Hum. Ecol. Risk Assess. 2004; 10: 79–90
   Web of Science ®Google Scholar
• Rhomberg L. R., Lewandowski T. A. Methods for identifying a default cross-species scaling factor. Hum. Ecol. Risk Assess. 2006; 12(6)1094–1127
   Web of Science ®Google Scholar
• Rhomberg L. R., Wolff S. K. Empirical scaling of single oral lethal doses across mammalian species based on a large database. Risk Anal. 1998; 18(6)741–753
   PubMed Web of Science ®Google Scholar
• Schmidt-Nielsen K. Scaling: Why is animal size so important?. Cambridge University Press, New York 1984
   Google Scholar
• Schneider K., Oltmanns J., Hassauer M. Allometric principles for interspecies extrapolation in toxicological risk assessment-empirical investigations. Regul. Toxicol. Pharmacol. 2004; 39(3)334–347
   PubMed Web of Science ®Google Scholar
• Slob W. Dose-response modeling of continuous endpoints. Toxicol. Sci. 2002; 66(2)298–312
   PubMed Web of Science ®Google Scholar
• Slob W., Pieters M. N. A probabilistic approach for deriving acceptable human intake limits and human health risks from toxicological studies: General framework. Risk Anal. 1998; 18(6)787–798
   PubMed Web of Science ®Google Scholar
• Travis C. C., White R. K. Interspecific scaling of toxicity data. Risk Anal. 1988; 8(1)119–125
   PubMedGoogle Scholar
• Travis C. C., White R. K., Ward R. C. Interspecies extrapolation of pharmacokinetics. J. Theor. Biol. 1990; 142(3)285–304
   PubMedGoogle Scholar
• van d en, Berg M., Birnbaum L., Bosveld A. T., Brunstrom B., Cook P., Feeley M., Giesy J. P., Hanberg A., Hasegawa R., Kennedy S. W., Kubiak T., Larsen J. C., van Leeuwen F. X., Liem A. K., Nolt C., Peterson R. E., Poellinger L., Safe S., Schrenk D., Tillitt D., Tysklind M., Younes M., Waern F., Zacharewski T. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 1998; 106(12)775–792
   PubMed Web of Science ®Google Scholar
• Vermeire T., Stevenson H., Pieters M. N., Rennen M., Slob W., Hakkert B. C. Assessment factors for human health risk assessment: A discussion paper. Crit. Rev. Toxicol. 1999; 29(5)439–490
   PubMed Web of Science ®Google Scholar
• Vocci F., Farber T. Extrapolation of animal toxicity data to man. Regul. Toxicol. Pharmacol. 1988; 8(4)389–398
   Google Scholar
• Watanabe K., Bois F. Y., Zeise L. Interspecies extrapolation: a reexamination of acute toxicity data. Risk Anal. 1992; 12(2)301–310
   PubMed Web of Science ®Google Scholar
• Zbinden G. Predictive value of animal studies in toxicology. Regul. Toxicol. Pharmacol. 1991; 14(2)167–177
   Google Scholar
• Zbinden G. The concept of multispecies testing in industrial toxicology. Regul. Toxicol. Pharmacol. 1993; 17(1)85–94
   Google Scholar